Preoperative sex steroids are significant predictors of early biochemical recurrence after radical prostatectomy

[1] Boorjian SA(2011)Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence Eur Urol 59 893-899

[2] Thompson RH(2010)Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy Eur Urol 57 562-568

[3] Tollefson MK(1998)Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 969-974

[4] Rangel LJ(2006)Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy J Natl Cancer Inst 98 715-717

[5] Bergstralh EJ(2011)Collagenase-3 expression by tumor cells and gelatinase B expression by stromal fibroblast-like cells are associated with biochemical recurrence after radical prostatectomy in patients with prostate cancer World J Urol 29 657-663

[6] Blute ML(2009)Testosterone and prostate cancer: revisiting old paradigms Eur Urol 56 48-56

[7] Karnes RJ(2010)Aromatase and regulating the estrogen:androgen ratio in the prostate gland J Steroid Biochem Mol Biol 118 246-251

[8] Lughezzani G(2004)High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy Am J Surg Pathol 28 928-934

[9] Budäus L(2007)Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy Eur Urol 52 696-701

[10] Isbarn H(2010)Testosterone therapy in men with androgen deficiency syndromes: an endocrine Society clinical practice guideline J Clin Endocrinol Metab 95 2536-2559

[1] Boorjian SA(2011)Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence Eur Urol 59 893-899

[2] Thompson RH(2010)Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy Eur Urol 57 562-568

[3] Tollefson MK(1998)Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 969-974

[4] Rangel LJ(2006)Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy J Natl Cancer Inst 98 715-717

[5] Bergstralh EJ(2011)Collagenase-3 expression by tumor cells and gelatinase B expression by stromal fibroblast-like cells are associated with biochemical recurrence after radical prostatectomy in patients with prostate cancer World J Urol 29 657-663

[6] Blute ML(2009)Testosterone and prostate cancer: revisiting old paradigms Eur Urol 56 48-56

[7] Karnes RJ(2010)Aromatase and regulating the estrogen:androgen ratio in the prostate gland J Steroid Biochem Mol Biol 118 246-251

[8] Lughezzani G(2004)High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy Am J Surg Pathol 28 928-934

[9] Budäus L(2007)Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy Eur Urol 52 696-701

[10] Isbarn H(2010)Testosterone therapy in men with androgen deficiency syndromes: an endocrine Society clinical practice guideline J Clin Endocrinol Metab 95 2536-2559